4.5 Article

Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia

期刊

GENOME BIOLOGY
卷 21, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13059-020-02030-2

关键词

PML-RAR alpha; ChIA-PET; 3D genome architecture; CTCF; RNA polymerase II (RNAPII); Transcription factor (TF); Transcriptional regulation; Super-enhancer (SE)

资金

  1. NIH [HG009409, DK107967]
  2. HFSP [RGP0039/2017]
  3. Roux family endowment
  4. NCI [P30CA034196]
  5. National Natural Science Foundation of China [31100942]
  6. Polish National Science Centre [2014/15/B/ST6/05082, UMO-2013/09/B/NZ2/00121]
  7. National Leading Research Centre in Bialystok
  8. European Union under the European Social Fund

向作者/读者索取更多资源

BackgroundAcute promyeloid leukemia (APL) is characterized by the oncogenic fusion protein PML-RAR alpha, a major etiological agent in APL. However, the molecular mechanisms underlying the role of PML-RAR alpha in leukemogenesis remain largely unknown.ResultsUsing an inducible system, we comprehensively analyze the 3D genome organization in myeloid cells and its reorganization after PML-RAR alpha induction and perform additional analyses in patient-derived APL cells with native PML-RAR alpha. We discover that PML-RAR alpha mediates extensive chromatin interactions genome-wide. Globally, it redefines the chromatin topology of the myeloid genome toward a more condensed configuration in APL cells; locally, it intrudes RNAPII-associated interaction domains, interrupts myeloid-specific transcription factors binding at enhancers and super-enhancers, and leads to transcriptional repression of genes critical for myeloid differentiation and maturation.ConclusionsOur results not only provide novel topological insights for the roles of PML-RAR alpha in transforming myeloid cells into leukemia cells, but further uncover a topological framework of a molecular mechanism for oncogenic fusion proteins in cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据